India Works On Public-Private Plans To Get Drugs To Poor
This article was originally published in PharmAsia News
Executive Summary
The Indian government plans to set up its own drug stores and even make drugs in some cases to make medicines more affordable in the poorer sections of the country. Part of the plan calls for partnerships with the private sector to produce generic copies of essential medicines. Other parts of the plan call for other public-private partnerships to be established to sell generics at half the price of the branded drugs they represent. Government representatives are discussing the plan with pharmacy associations and makers of generic drugs. The program also would set up special drug stores in poorer sections to sell the reduced-price drugs. (Click here for more
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.